Inhibrx shares owned by Ubs Global Asset Management Americas
Quarter-by-quarter ownership of Inhibrx shares owned by Ubs Global Asset Management Americas
from 13F filings
Historical chart of Ubs Global Asset Management Americas investment in Inhibrx
Tip: Access up to 7 years of quarterly data
All positions including Inhibrx held by Ubs Global Asset Management Americas consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Inhibrx by Ubs Global Asset Management Americas
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $1.0M | 30k | 34.96 |
2023-12-31 | $1.2M | 32k | 38.00 |
2023-09-30 | $591k | 32k | 18.35 |
2022-12-31 | $435k | 18k | 24.64 |
2022-06-30 | $114k | 10k | 11.35 |
More positions owned by Ubs Global Asset Management Americas
View all positions for Ubs Global Asset Management Americas